Full Clinical Guidelines - Community First Health Plans.

More documents

Recommendations

Info

1 Adapted from NIH/NHLBI/NAASO;1998; NIH Publication No. 98-4083 (Obes Res 1998;6[Suppl 2]:51S-210S) 2 Consider starting obesity pharmacotherapy concurrent with other treatment modalities at presentation in motivated/adherent pts if BMI >35 with comorbidities or >40 with no comorbidities 3 National Cholesterol Education Program-Adult Treatment Panel III. JAMA 2001;285:2466-97 4 American Association of <strong>Clinical</strong> Endocrinologists Consensus Conference on the Insulin Resistance Syndrome, Washington, DC; August 2002 (Diabetes Care 2003;26:1297- 1303) 5 The 7th Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC 7). JAMA 2003;289:2560-72 6 See Glycemic Control Algorithm in Type 2 Diabetes Mellitus in Children and Adults; Diabetes medications may need to be adjusted to avoid hypoglycemia in pts who lose wt 8 Assuming BMI >25 and/or waist circumference >40 inches in men; >35 inches in women and 1 or more major comorbidity 9 Calorie deficit of 250 Kcal/day will result in ~1/2 lb/week wt loss (1000 Kcal/day ~2 lb/week wt loss) 10FDA-approved for adjunctive short-term use
Publication #45-11825 Screening 1 : 1. General population; BMI >25 Individuals >45 years Baseline and q 3 years 2. High risk population >18 years; BMI >25 Baseline and yearly 3. Children and youth at risk Baseline at age 10 and q 2 years • Overweight BMI (>85th %’ile for age and gender and > two risk factors) Risk Factors: • 1st degree (and/or 2nd degree in children) relative with diabetes • Hx of gestational diabetes or delivery of a baby weighing >9 lbs • High-risk ethnic group • Hypertension • Dyslipidemia • Polycystic Ovary Syndrome • Metabolic 2 and/or Insulin Resistance 3 Syndromes • Vascular disease • Acanthosis nigricans TESTING 1,4,5 : FPG Recommended: (if abnormal confirm X 1); however 2-hr OGTT acceptable in adults and should be used for diagnosis in children 6 (routine measurement of insulin levels is not recommended) a Diagnosis: IFG FPG >100 and 140 and 126 mg/dL and/or 2-hr OGTT >200 mg/dL— Refer to Texas Diabetes Council Algorithms BMI—Body mass index (kg/m 2 ) FPG—Fasting plasma glucose OGTT—1.75g/kg to max 75g Oral glucose tolerance test PCP—Primary care provider NORMAL FPG
Page 1 and 2:
Community First Health Plans Qualit
Page 3 and 4:
10.5 ATP III Classification of Chol
Page 5 and 6:
Such information is released only t
Page 7 and 8:
Non Voting • Martin Jimenez, Dire
Page 9 and 10:
The purpose of these guidelines is
Page 11 and 12: Table 1. Adult Preventive Services
Page 13 and 14: Recommended Adult Immunization Sche
Page 15 and 16: Footnotes — Recommended Adult Imm
Page 17 and 18: CFHP has adopted the National Asthm
Page 19 and 20: Patient Name ______________________
Page 21 and 22: Managing Asthma Long Term 41 FIGURE
Page 23 and 24: FIGURE 14. CLASSIFYING ASTHMA SEVER
Page 25 and 26: FIGURE 16. STEPWISE APPROACH FOR MA
Page 27 and 28: FIGURE 20. CLASSIFYING SEVERITY OF
Page 29 and 30: II. Some hyperactive-impulsive or i
Page 31 and 32: COMMUNITY FIRST HEALTH PLANS BEHAVI
Page 33 and 34: Criteria Requirements 33. Release o
Page 35 and 36: The evaluation of breast disease is
Page 37 and 38: Prevent Child Texas, a non-profit o
Page 39 and 40: AMERICAN ACADEMY OF PEDIATRICS: Fai
Page 41 and 42: possible), a careful, complete, and
Page 43 and 44: Examination/Test Oral / Dental Insp
Page 45 and 46: GLYCEMIC CONTROL BIBLIOGRAPHY • R
Page 47 and 48: Publication # 45-11647 Targets* A1
Page 49 and 50: WORKSHEET Revised 10-20-05 Advancin
Page 51 and 52: D. Optimizing analog insulin use Re
Page 53 and 54: Publication # 45-11266 Age 126 mg/d
Page 55 and 56: Hypertension Algorithm for Diabetes
Page 57 and 58: Lipid Algorithm For Type 1 and Type
Page 59 and 60: References: Revised 1-24-08 • Col
Page 61: WEIGHT LOSS ALGORITHM FOR OVERWEIGH
Page 65 and 66: Publication #45-12000 DIABETIC FOOT
Page 67 and 68: DIABETIC FOOT CARE/REFERRAL ALGORIT
Page 69 and 70: Publication # 45-12083 WEIGHT MANAG
Page 71 and 72: 9 H EALTH PLANS www.cfhp.com 71
Page 73 and 74: Revised 10-25-07 IV INSULIN INFUSIO
Page 75 and 76: Revised 10-25-07 Publication #: 45-
Page 77 and 78: Revised 2-21-08 Publication #: E45-
Page 79 and 80: Abbreviations AGI Alpha-Glucosidase
Page 81 and 82: Orders for Adults with DKA and Hype
Page 83 and 84: D i a b e t e s t r e a t m e n t a
Page 85 and 86: CFHP has adopted the National Insti
Page 87 and 88: No CHD; 0 to 1, or 2+ Risk Factors
Page 89 and 90: NATIONAL CHOLESTEROL EDUCATION PROG
Page 91 and 92: NATIONAL CHOLESTEROL EDUCATION PROG
Page 93 and 94: Identification, Evaluation, and Tre
Page 95 and 96: 11.3 Treatment of Hypertension H EA
Page 97 and 98: ALGORITHM FOR TREATMENT OF MAJOR DE
Page 99 and 100: CFHP has established guidelines for
Page 101 and 102: A. Documentation ______ B. Continui
Page 103 and 104: CFHP PCP MEDICAL RECORD REVIEW TOOL
Page 105 and 106: 13.3 Specialist Medical Record Docu
Page 107 and 108: 13.4 Specialist Medical Record Revi
Page 109 and 110: Risk Factors for Osteoporosis Fract
Page 111 and 112: It is well documented that obesity
Page 113 and 114:
CLASSIFICATION OF OVERWEIGHT AND OB
Page 115 and 116:
16.1.1 Preventive Pediatric Health
Page 117 and 118:
H EALTH PLANS www.cfhp.com 117
Page 119 and 120:
TEXAS MEDICAID PROVIDER PROCEDURES
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
CHILDREN’S SERVICES HANDBOOK P h
Page 127 and 128:
CHILDREN’S SERVICES HANDBOOK P R
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
H EALTH PLANS www.cfhp.com 139
Page 141 and 142:
FIGURE 2: Recommended immunization
Page 143 and 144:
Comprehensive antepartum care is vi
Page 145 and 146:
The following variables should be e
Page 147 and 148:
CRITERIA 19. Unresolved Problems Fr
Page 149 and 150:
CFHP OB/GYN SPECIALTY MEDICAL RECOR
Page 151 and 152:
CFHP OB/GYN SPECIALTY MEDICAL RECOR
Page 153 and 154:
According to the National Institute
Page 155 and 156:
. aminotransferase (AST) and alanin
Page 157 and 158:
PREVENTION RECOMMENDATIONS 1. The E
Page 159 and 160:
2 to 20 years: Boys Body mass index
Page 161 and 162:
AsthmaMatters is an initiative deve
Page 163 and 164:
According to the Centers for Diseas
show all

Full Clinical Guidelines - Community First Health Plans.

Create successful ePaper yourself

Delete template?

Save as template?